Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | CA3 | P07451 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 1/20 | 0.65 |
| ▸ | CA6 | P23280 | 1/20 | 0.65 |
| ▸ | CA5A | P35218 | 1/20 | 0.65 |
| ▸ | CA7 | P43166 | 1/20 | 0.65 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.65 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 1/20 | 0.65 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.65 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.50 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1694611 | 1.00 | CA12 (0.65) | CA12CA1CA2CA3CA4 | |
| SCHEMBL42110 | 1.00 | CA12 (0.65) | CA12CA1CA2CA3CA4 | |
| SCHEMBL30968896 | 1.00 | CA12 (0.65) | CA12CA1CA2CA3CA4 | |
| Oxalic Acid SCHEMBL1694196 | 0.97 | CA12 (0.62) | CA12CA1CA2CA3CA4 | |
| Oxalic Acid SCHEMBL2236217 | 0.97 | CA12 (0.62) | CA12CA1CA2CA3CA4 | |
| Toluene SCHEMBL15670046 | 0.94 | CA12 (0.59) | CA12CA1CA2CA3CA4 | |
| Hydrochloric Acid SCHEMBL3458139 | 0.91 | CA1 (0.59) | CA12CA1CA2CA3CA4 | |
| Hydrochloric Acid SCHEMBL3458138 | 0.91 | CA1 (0.59) | CA12CA1CA2CA3CA4 | |
| SCHEMBL2518744 | 0.90 | CA12 (0.53) | CA12CA1CA2CA3CA4 | |
| SCHEMBL13015859 | 0.86 | PKM (0.55) | CA12CA1CA2CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3375771-B1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | UBE CORP (JP) | 2025-11-26 | — | — | EP | claimed |
| CN-119335094-A | Reversed-phase liquid chromatography method for detecting lacosamide dry syrup related substances | 海南卫康制药(潜山)有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118056817-A | Industrial synthesis method of GS6207 key intermediate | 苏州匠化生物科技有限公司 | 2024-05-21 | — | — | CN | claimed |
| CN-115108933-B | Synthesis method of lacosamide | 上药康丽（常州）药业有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-115108933-A | Synthetic method of lacosamide | 上药康丽（常州）药业有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-114685317-A | Preparation method of medicine for treating epilepsy | 成都硕德药业有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113816869-A | Preparation method of lacosamide process impurities | 河北广祥制药有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-10414720-B2 | Process for the preparation of lacosamide | UNICHEM LABORATORIES LTD. (IN) | 2019-09-17 | — | — | US | claimed |
| CN-106866453-B | A kind of method that microreactor prepares scheme for lacosamide | 齐鲁天和惠世制药有限公司 | 2019-03-22 | — | — | CN | claimed |
| CN-106866453-A | A kind of method that microreactor prepares scheme for lacosamide | 齐鲁天和惠世制药有限公司 | 2017-06-20 | — | — | CN | claimed |
| EP-2399901-A1 | Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide | Archimica GmbH (DE) | 2011-12-28 | — | — | EP | claimed |
| WO-2011158194-A1 | ENZYMATIC RESOLUTION OF RACEMIC (2R,S)-2-(ACETYLAMINO)-3-METHOXY-N-(PHENYLMETHYL)PROPANAMIDE | MEDICHEM, S.A. (ES) | 2011-12-22 | — | — | WO | claimed |
| WO-2011099033-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| US-20110130350-A1 | SYNTHESIS SCHEME FOR LACOSAMIDE | UCB PHARMA GMBH (DE) | 2011-06-02 | — | — | US | claimed |
| US-7884134-B2 | From 2-(N-protected amino)-3-methoxypropionic acid; improved enantiomeric purity; O-methylation of serine derivatives | UCB PHARMA GMBH (DE) | 2011-02-08 | — | — | US | claimed |
| EP-1799635-B1 | IMPROVED SYNTHESIS SCHEME FOR LACOSAMIDE | SANOL ARZNEI SCHWARZ GMBH (DE) | 2010-02-17 | — | — | EP | claimed |
| US-20080027137-A1 | Synthesis Scheme for Lacosamide | SCHWARZ PHARMA AG (DE) | 2008-01-31 | — | — | US | claimed |
| EP-1799635-A1 | IMPROVED SYNTHESIS SCHEME FOR LACOSAMIDE | SCHWARZ PHARMA AG (DE) | 2007-06-27 | — | — | EP | claimed |
| WO-2006037574-A1 | IMPROVED SYNTHESIS SCHEME FOR LACOSAMIDE | SCHWARZ PHARMA AG (DE) | 2006-04-13 | — | — | WO | claimed |
| EP-1642889-A1 | Improved synthesis scheme for lacosamide | SCHWARZ PHARMA AG (DE) | 2006-04-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027137-A1 | Synthesis Scheme for Lacosamide | RIMKLA, GNMT, NAAA | CA12 66/4885CA1 58/4885CA2 76/4885 |
| US-10414720-B2 | Process for the preparation of lacosamide | DNPEP, MGMT, NAAA | CA12 68/4885CA1 45/4885CA2 328/4885 |
| US-20110130350-A1 | SYNTHESIS SCHEME FOR LACOSAMIDE | RIMKLA, GNMT, MYT1 | CA12 101/4885CA1 56/4885CA2 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.